✦ LIBER ✦

Prophylaxis of Radiation-Induced Nausea and Vomiting Using 5-Hydroxytryptamine-3 Serotonin Receptor Antagonists: A Systematic Review of Randomized Trials

✍ Scribed by Nadia Salvo; Brett Doble; Luluel Khan; Gayathri Amirthevasar; Kristopher Dennis; Mark Pasetka; Carlo DeAngelis; May Tsao; Edward Chow

Book ID: 118455294
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 235 KB
Volume: 82
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2010.08.060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of postoperative nausea and

Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists

✍ Anthony L. Kovac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Efficacy of 5-HT3 receptor antagonists i

Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review

✍ M.R Tramèr; D.J.M Reynolds; N.S Stoner; R.A Moore; H.J McQuay 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Timing and duration of 5-HT3receptor ant

Timing and duration of 5-HT3receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies

✍ Kristopher Dennis, Leila Makhani, Ernesto Maranzano… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 213 KB

RETRACTED ARTICLE: Current prevention an

RETRACTED ARTICLE: Current prevention and treatment of postoperative nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists: a review

✍ Yoshitaka Fujii; Hidenori Toyooka 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 73 KB

GR38032F, a 5HT3receptor antagonist, in

GR38032F, a 5HT3receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting

✍ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as

PGI5 A META-ANALYSIS OF THE 5-HT3 RECEPT

PGI5 A META-ANALYSIS OF THE 5-HT3 RECEPTOR ANTAGONISTS USE IN POST-OPERATIVE NAUSEA AND VOMITING PROPHYLAXIS

✍ D Tang; DC Malone 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB